HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nehmat Ghaboura Selected Research

Glycogen Synthase Kinase 3 beta

12/2009Myocardial reperfusion injury management: erythropoietin compared with postconditioning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nehmat Ghaboura Research Topics

Disease

3Ischemia
11/2011 - 06/2010
2Reperfusion Injury
01/2011 - 12/2009
1Neuroinflammatory Diseases
02/2022
1Alzheimer Disease (Alzheimer's Disease)
02/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2022
1Multiple Sclerosis
02/2022
1Huntington Disease (Huntington's Disease)
02/2022
1Inflammation (Inflammations)
02/2022
1Brain Diseases (Brain Disorder)
02/2022
1Parkinson Disease (Parkinson's Disease)
02/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022
1Diabetes Mellitus
01/2011
1Insulin Resistance
01/2011
1Infarction (Infarctions)
06/2010
1Myocardial Infarction
06/2010
1Myocardial Reperfusion Injury
12/2009

Drug/Important Bio-Agent (IBA)

3ErythropoietinFDA Link
01/2011 - 12/2009
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
02/2022
1AntioxidantsIBA
02/2022
1Carotenoids (Carotene)IBA
02/2022
1diazonaphthalenedisulfonic acid (NDS)IBA
02/2022
1Protein AggregatesIBA
02/2022
1Phosphotransferases (Kinase)IBA
01/2011
1Streptozocin (Streptozotocin)FDA Link
01/2011
1triphenyltetrazoliumIBA
06/2010
1salicylhydroxamic acid (SHAM)IBA
06/2010
1Glycogen Synthase Kinase 3 betaIBA
12/2009

Therapy/Procedure

2Ischemic Postconditioning
11/2011 - 12/2009